To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreDate | Time | Trade Prc | Volume | Buy/Sell | Value | |
---|---|---|---|---|---|---|
26-Apr-24 | 17:51:28 | 610.00 | 400 | Unknown* | 2,440 | O Ordinary Was reported as OTC |
26-Apr-24 | 16:35:17 | 616.00 | 15 | Buy* | 92.40 | UT Uncrossing Trade |
26-Apr-24 | 16:25:51 | 615.04 | 3 | Buy* | 18.45 | O Ordinary |
26-Apr-24 | 16:13:35 | 615.04 | 32 | Buy* | 196.81 | O Ordinary |
26-Apr-24 | 16:11:52 | 612.2175 | 996 | Sell* | 6,098 | O Ordinary |
26-Apr-24 | 16:01:44 | 612.00 | 600 | Buy* | 3,672 | A Automatic Execution |
26-Apr-24 | 15:49:17 | 611.518 | 410 | Buy* | 2,507 | O Ordinary |
26-Apr-24 | 15:35:39 | 609.683 | 1,500 | Sell* | 9,145 | O Ordinary |
26-Apr-24 | 15:08:47 | 609.6815 | 271 | Sell* | 1,652 | O Ordinary |
26-Apr-24 | 15:00:34 | 608.5163 | 1,586 | Sell* | 9,651 | O Ordinary |
26-Apr-24 | 14:58:24 | 611.28 | 490 | Buy* | 2,995 | O Ordinary |
26-Apr-24 | 14:57:37 | 608.5141 | 901 | Sell* | 5,483 | O Ordinary |
26-Apr-24 | 14:46:34 | 608.5081 | 180 | Sell* | 1,095 | O Ordinary |
26-Apr-24 | 14:44:15 | 610.00 | 400 | Buy* | 2,440 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 14:44:07 | 611.28 | 1,450 | Buy* | 8,864 | O Ordinary |